| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/16/2009 | US7547549 Method to produce a hybrid cell having a single mitochondrial genotype |
| 06/16/2009 | US7547548 Reprogramming plant development to allow flower buds and seeds to arise de novo, directly from a cotyledon or radicle explants or from shoots produced on a cotyledon or radicle |
| 06/16/2009 | US7547547 Bioprocess for producing uniform embryoid bodies from embryonic stem cells in a high density bioreactor |
| 06/16/2009 | US7547545 Directed in vitro differentiation of marrow stromal cells into neural cell progenitors |
| 06/16/2009 | US7547543 Retinoid-Related Orphan Receptor (ROR) receptor response element ; drug screening |
| 06/16/2009 | US7547541 In vitro fertilisation |
| 06/16/2009 | US7547535 Mutant form of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase (PQQ) monitoring glucose level in blood, serum and urine |
| 06/16/2009 | US7547534 Catalyzing hydrolysis of xylans in beverage, feed, food or polysaccharide to produce a smaller molecular weight xylose and xylo-oligomer; have increased activity and stability at increased pH and temperature; catalyzing hydrolysis of internal beta -1,4-xylosidic or endo- beta -1,4-glucanase linkages |
| 06/16/2009 | US7547531 L-amino acid producing microorganism which has been modified to inactive the fimH gene, and a method for producing I-amino acid |
| 06/16/2009 | US7547529 Formation of a by-product polypeptide containing an O-acetylserine residue in place of a serine residue by adding histidine, methionine or glycine to the medium in culturing transformed cells |
| 06/16/2009 | US7547528 Expression vector comprising nucleotide sequences coding coral fluorescent protein for use as reporter molecules in genetic engineering |
| 06/16/2009 | US7547523 Drug screening for agonists and antagonists of the mammalian histamine receptor; for inflammation, asthma, and allergy, atopic dermatitis, stroke, myocardial infection, migraine, COPD, rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, and psoriasis |
| 06/16/2009 | US7547522 Genetic manipulation of nonhuman animals to be used for xenotransplantation; null swine; obtaining a line of cells from a GGTA1 heterozygous swine, enriching them by treatment with agents that specifically bind alpha (1,3)-galactose epitope and deplete cells that do not, scanning for viable cells |
| 06/16/2009 | US7547521 Heteromultimeric ion channel receptor and uses thereof |
| 06/16/2009 | US7547513 Mutants of deoxycytidine kinase having extended enzymatic activity |
| 06/16/2009 | US7547512 Nucleotide sequences comprisied of spike and nucleocapsid coding sequence for use as amplification tool in detection of coronaviral infection |
| 06/16/2009 | US7547511 Antisense inhibition of laminin-8 expression to inhibit human gliomas |
| 06/16/2009 | US7547510 Isolating heat resistant cellulase from bacillus culture using temperature variance and fraction separation |
| 06/16/2009 | US7547442 Newcastle disease virus infectious clones, vaccines and new diagnostic assays |
| 06/16/2009 | US7547439 Elicit immune response from human lymphocytes when complexed with a major histocompatibility complex molecule type HLA-A2; polypeptide |
| 06/16/2009 | US7547438 CD40-binding activating antibodies |
| 06/16/2009 | US7547395 Formed by polymerizing, under freezing, aqueous solution of acrylamide and N,N-methylene-bis-acrylamide, in presence of initiator system, thawing, transamidating with ethylenediamine, treating with divinylsulfone and iminodiacetic acid, then loading copper ions; chromatographic/electrical separations |
| 06/16/2009 | CA2497493C Adsorption of nucleic acids to a solid phase |
| 06/16/2009 | CA2399910C Mammalian secreted group iii phospholipase a2 |
| 06/16/2009 | CA2399900C Dehiscence gene and methods for regulating dehiscence |
| 06/16/2009 | CA2326327C Recombinant adeno-associated virus vector encoding alpha-1-antitrypsin serum protein |
| 06/16/2009 | CA2319437C Methods and reagents for decreasing allergic reactions |
| 06/16/2009 | CA2282727C Cell surface molecule mediating cell adhesion and signal transmission |
| 06/16/2009 | CA2266439C Neutrokine .alpha. |
| 06/16/2009 | CA2255101C Immunoreactive regions of glycoprotein gpii of varicella zoster virus (vzv) |
| 06/16/2009 | CA2251391C Process for the production of plants with enhanced growth characteristics |
| 06/16/2009 | CA2158322C Immunoconjugate comprising an anti-egf receptor antibody and interleukin-8 |
| 06/11/2009 | WO2009073844A1 Chimeric and proline rich protein promoters for expression in plants |
| 06/11/2009 | WO2009073822A2 Molecular approaches for the optimization of biofuel production |
| 06/11/2009 | WO2009073821A2 Biopolymer-nucleic acid conjugation |
| 06/11/2009 | WO2009073820A2 Biopolymer-nucleic acid conjugation |
| 06/11/2009 | WO2009073808A2 Compositions and methods to modulate cell membrane resealing |
| 06/11/2009 | WO2009073738A1 Seed-preferred gene promoters from the castor plant |
| 06/11/2009 | WO2009073618A2 Compositions comprising hdac inhibitors and methods of their use in restoring stem cell function and preventing heart failure |
| 06/11/2009 | WO2009073605A2 Drought tolerant plants and related constructs and methods involving genes encoding ferrochelatases |
| 06/11/2009 | WO2009073527A2 Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases |
| 06/11/2009 | WO2009073478A2 Tle3 as a marker for chemotherapy |
| 06/11/2009 | WO2009073471A1 Recombinantly modified plasmin |
| 06/11/2009 | WO2009073460A2 Inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 for ocular neuroprotection |
| 06/11/2009 | WO2009073330A2 Novel vaccines against multiple subtypes of influenza virus |
| 06/11/2009 | WO2009073160A1 Anti-vegf antibodies |
| 06/11/2009 | WO2009073104A2 Simian e adenoviruses sadv-39, -25. 2, -26, -30, -37, and -38 |
| 06/11/2009 | WO2009073069A2 Genes and uses for plant enhancement |
| 06/11/2009 | WO2009072972A1 A method for enzymatic joining of a dsrna adapter to a dsrna molecule |
| 06/11/2009 | WO2009072883A1 Methods for generating marker free transgenic plants |
| 06/11/2009 | WO2009072882A1 Animals of the rattus genus wherein msh6 expression is functionally decreased and methods for the generation of specific mutants there from |
| 06/11/2009 | WO2009072835A2 Transgenic cats expressing red fluorescence protein and producing method thereof |
| 06/11/2009 | WO2009072811A1 Method for marking bio-information into genome of organism and organism marked with the bio-information |
| 06/11/2009 | WO2009072726A1 Method for large scale preparation of the active domain of human protein tyrosine phosphatase without fusion protein |
| 06/11/2009 | WO2009072676A1 Transformed plant with promoted growth |
| 06/11/2009 | WO2009072660A1 Method for production of antibody |
| 06/11/2009 | WO2009072628A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 06/11/2009 | WO2009072609A1 Gene capable of increasing the production of oil-and-fat in plant, and use thereof |
| 06/11/2009 | WO2009072608A1 Gene capable of increasing the production of oil-and-fat in plant, and use thereof |
| 06/11/2009 | WO2009072604A1 Anti-nr10 antibody and use thereof |
| 06/11/2009 | WO2009072593A1 Expression cassette for lactase dehydrogenase, transformed yeast and method of producing lactic acid |
| 06/11/2009 | WO2009072588A1 Monoclonal antibody responsive to mouse polymeric immunoglobulin receptor |
| 06/11/2009 | WO2009072562A1 Process for production of organic acid |
| 06/11/2009 | WO2009072542A1 Transgenic plant capable of flowering at low light intensity |
| 06/11/2009 | WO2009072508A1 Medical composition for implantation |
| 06/11/2009 | WO2009072147A1 Chimeric construct of mungbean yellow mosaic india virus (mymiv) and its uses thereof |
| 06/11/2009 | WO2009072118A1 Transgenic plants having altered levels of aromatic amino acids and metabolites derived therefrom |
| 06/11/2009 | WO2009071920A2 Methods for identifying epigenetically silenced genes and novel tumour suppressor genes |
| 06/11/2009 | WO2009071914A2 Mutant proteins and methods for producing them |
| 06/11/2009 | WO2009071732A1 Np1 activity regulating elements which can be used in the production of drugs for the treatment or prevention of human neurodegenerative diseases, resulting drugs and use thereof |
| 06/11/2009 | WO2009071722A1 METHODS AND KITS FOR PREPARING GENE LIBRARIES OF SPECIFIC siRNAs OF A TRANSCRIPTOME BY MEANS OF CONVERGENT TRANSCRIPTION |
| 06/11/2009 | WO2009071681A2 Rna antagonist compounds for the modulation of bcl-2 |
| 06/11/2009 | WO2009071680A2 Rna antagonist compounds for the modulation of mcl-1 |
| 06/11/2009 | WO2009071679A1 Novel aav vector and uses thereof |
| 06/11/2009 | WO2009071660A1 Use of protease nexin 1 inhibitors to reduce metastasis |
| 06/11/2009 | WO2009071659A1 Trophic factor for the treatment of retinal degenerative diseases |
| 06/11/2009 | WO2009071550A1 Protease variants for pharmaceutical use |
| 06/11/2009 | WO2009071530A1 Fungal pepc inhibitor |
| 06/11/2009 | WO2009071488A2 Hcv ns3 protease replicon shuttle vectors |
| 06/11/2009 | WO2009071334A2 Transposon-mediated mutagenesis in spermatogonial stem cells |
| 06/11/2009 | WO2009071082A2 Rna antagonist compounds for the modulation of pik3ca expression |
| 06/11/2009 | WO2009070929A1 A subunit vaccine for aquaculture |
| 06/11/2009 | WO2009070872A1 Method of increasing erucic acid production by hairpin rna fad2 gene silencing and fae gene overexpression |
| 06/11/2009 | WO2009070822A2 Recombinant pichia pastoris cell |
| 06/11/2009 | WO2009055724A3 High throughput methods for functionally determining rna interference efficiency |
| 06/11/2009 | WO2009054713A8 Detection of epstein-barr virus (ebv) in nasopharyngeal cancer |
| 06/11/2009 | WO2009054660A3 Method for increasing salt tolerance of plant by overexpressing syfbp/sbpase gene isolated from synechocystis and plant produced by the same |
| 06/11/2009 | WO2009053937A3 Nano-lipid-based carriers for targeted delivery of viral vectors and process for its production |
| 06/11/2009 | WO2009042457A4 Nucleic acid isolation in preserved whole blood |
| 06/11/2009 | WO2009040113A3 C5a BINDING NUCLEIC ACIDS |
| 06/11/2009 | WO2009037183A3 Cosmetic and/or pharmaceutical preparation containing nucleic acid for the induction of antimicrobial peptides in epithelia |
| 06/11/2009 | WO2009034190A3 Affinity tag |
| 06/11/2009 | WO2009033120A3 Use of iridoptin to induce toxicity in insects |
| 06/11/2009 | WO2009032185A3 Functional assay for indentification of loss-of-function mutations in genes |
| 06/11/2009 | WO2009027978A8 NUCLEIC ACID SEQUENCES COMPRISING NF-ϰB BINDING SITE WITHIN O(6)-METHYLGUANINE-DNA-METHYLTRANSFERASE (MGMT) PROMOTER REGION AND USES THEREOF FOR THE TREATMENT OF CANCER AND IMMUNE-RELATED DISORDERS |
| 06/11/2009 | WO2009019613A3 [nife]-hydrogenases having an improved resistance to dioxygen, process for obtaining them and their applications |
| 06/11/2009 | WO2009015268A3 Engineered glycosyltransferases with expanded substrate specificity |
| 06/11/2009 | WO2008156500A4 Methods of inducing or increasing the expression of proteoglycans such as aggrecan in cells |
| 06/11/2009 | WO2008150897A3 Reduction of off-target rna interference toxicity |
| 06/11/2009 | WO2008150495A8 vWF APTAMER FORMULATIONS AND METHODS FOR USE |